MicroRNA | Xconomy

by in

Entry	Blogger	Date ▴	Location
MicroRNA Leaps Ahead: Alnylam-Isis Venture, Regulus, Shows Its Drug Works in Animals With Heart Failure	Luke Timmerman	11/30/08	San Diego
Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments	Luke Timmerman	10/24/08	San Diego
Dendreon Proceeds With Prostate Cancer Clinical Trials, AXI Gets Oil from Algae, PATH Prepares to Launch “Ultra Rice,” & More Deals News	Gregory T. Huang	08/18/08	Seattle
Accelerator Bankrolls New Company, Mirina, To Develop MicroRNA-Blocking Drugs	Luke Timmerman	08/15/08	Seattle
Rocky Mountain High: Atlas Venture Is Banking on microRNA for Miragen	Gregory T. Huang	05/22/08	Boston
Alnylam Joint Venture Regulus Inks Deal with GSK Worth up to $600 Million	Erik Mellgren	04/17/08	Boston
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.